Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.

Vassall, A; Pickles, M; Chandrashekar, S; Boily, MC; Shetty, G; Guinness, L; Lowndes, CM; Bradley, J; Moses, S; Alary, M; +2 more... Charme India Group; Vickerman, P; (2014) Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India. The Lancet Global health, 2 (9). e531-40. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(14)70277-3

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2214-109X(14)70277-3

Abstract

Share

Download

Filename: Cost-eff ectiveness of HIV prevention_GOLD VoR.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar